![]() |
市場調查報告書
商品編碼
1701929
下腔靜脈過濾器市場按產品、材料、應用(治療靜脈血栓栓塞、預防肺栓塞等)、最終用戶(醫院、門診手術中心等)和地區分類,2024 年至 2032 年Inferior Vena Cava Filter Market by Product, Material, Application (Treatment Venous Thromboembolism, Prevent Pulmonary Embolism, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2024-2032 |
2024 年全球下腔靜脈 (IVC) 過濾器市場規模達 7.69 億美元。展望未來, IMARC Group預計到 2033 年市場規模將達到 14.09 億美元,2025-2033 年期間的成長率 (CAGR) 為 7%。深部靜脈栓塞 (DVT) 和肺栓塞 (PE) 盛行率的不斷上升、消費者對疾病風險和後果的認知不斷提高、對微創手術的偏好日益增加是推動市場發展的一些主要因素。
下腔靜脈 (IVC) 過濾器是一種醫療設備,旨在防止血栓從下半身遷移到肺部並降低肺栓塞的風險。它是一種由金屬或合成材料製成的小型籠狀結構。它被插入下腔靜脈,將脫氧血液從下半身輸送到心臟。它透過捕獲血塊並阻止其進入肺部來充當物理屏障。
目前,血栓高風險患者擴大採用 IVC 過濾器,這促進了市場的成長。除此之外,由於醫療保健提供者的優惠報銷政策,IVC 過濾器的使用率不斷上升,推動了市場的成長。此外,由於老年人更容易發生靜脈血栓栓塞,因此擴大採用 IVF 過濾器,這也促進了市場的成長。此外,由於全球大眾對微創手術的偏好日益增加,對 IVC 過濾器的需求不斷成長,這對市場產生了積極影響。此外,由於醫療基礎設施的改善,醫療解決方案的採用率不斷提高,從而增強了市場的成長。
深部靜脈血栓(DVT)和肺栓塞(PE)盛行率上升
由於全球深部靜脈栓塞 (DVT) 和肺栓塞 (PE) 的盛行率不斷上升,對 IVC 過濾器的需求也在增加。深部靜脈血栓形成通常發生在深層靜脈(通常在腿部)形成血栓時。此外,如果這些血塊脫落並進入肺部,則可能導致一種稱為肺栓塞的危及生命的疾病。由於久坐不動的生活方式、肥胖、不當的體力活動和其他生活方式相關問題,人們面臨越來越多的 DVT 和 PE 病例。此外,老年族群罹患 DVT 的幾率也會增加。此外,醫療保健提供者擴大採用 IVC 過濾器作為高風險患者的預防措施,以減少 PE 的發生及其相關發病率和死亡率。
提高消費者對疾病風險和後果的認知
隨著醫療專業人員和一般民眾對 DVT 和 PE 的風險和後果的認知不斷提高,對 IVC 過濾器的需求也在增加。
各國管理機構正在透過傳播意識、組織活動和採取教育措施來鼓勵採用下腔靜脈過濾器,重點是預防靜脈血栓栓塞症。此外,診斷能力的快速進步使得能夠更準確、及時地檢測 DVT 和 PE 病例,從而改善患者的治療效果。此外,早期診斷可以讓醫療專業人員識別出哪些人可以從 IVC 過濾器植入中受益。下腔靜脈過濾器的使用率不斷提高,為預防肺栓塞提供了可靠且有效的解決方案,促進了市場的成長。
IVC 過濾器技術的進步
各製造商正在迅速推進 IVC 過濾技術,以提高產品的安全性和有效性。此外,可回收下腔靜脈過濾器的使用日益增多,一旦肺栓塞風險消除,就可以取出。這些可回收過濾器為醫療保健專業人員提供了更多靈活性和有效管理患者的選擇,這帶來了積極的市場前景。此外,過濾器設計和材料的各種技術進步有助於增強生物相容性並降低不良反應和長期併發症的風險。除此之外,由於其有效性的提高,IVC 過濾器在適當情況下的採用率也在上升。
The global inferior vena cava (IVC) filter market size reached USD 769.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,409.0 Million by 2033, exhibiting a growth rate (CAGR) of 7% during 2025-2033. The growing prevalence of deep vein thrombosis (DVT) and pulmonary embolism (PE), rising consumer awareness about the risks and consequences of diseases, and increasing preference for minimally invasive surgical procedures are some of the major factors propelling the market.
An inferior vena cava (IVC) filter is a medical device that is designed to prevent the migration of blood clots from the lower body to the lungs and reduce the risk of pulmonary embolism. It is a small and cage-like structure that is manufactured from metal or synthetic materials. It is inserted into the inferior vena cava vein that carries deoxygenated blood from the lower body to the heart. It acts as a physical barrier by trapping blood clots and preventing them from reaching the lungs.
At present, the increasing adoption of IVC filters among patients who are at high risk of developing blood clots is contributing to the growth of the market. Apart from this, the rising utilization of IVC filters on account of favorable reimbursement policies by healthcare providers is propelling the growth of the market. Moreover, the increasing adoption of IVF filters among the geriatric population, as they are more prone to venous thromboembolism, is bolstering the growth of the market. Additionally, the growing demand for IVC filters due to the increasing preference for minimally invasive surgical procedures among the masses around the world is positively influencing the market. Furthermore, the rising adoption of medical treatment solutions due to the improving healthcare infrastructure is strengthening the growth of the market.
Rising prevalence of deep vein thrombosis (DVT) and pulmonary embolism (PE)
There is a rise in the demand for IVC filters due to the increasing prevalence of deep vein thrombosis (DVT) and pulmonary embolism (PE) among the masses across the globe. Deep vein thrombosis usually occurs when blood clots form in deep veins, often in the legs. Moreover, if these clots break loose and travel to the lungs, then they can cause a life-threatening condition known as pulmonary embolism. People are increasingly facing DVT and PE cases due to sedentary lifestyles, obesity, improper physical activity, and other lifestyle-related issues. Additionally, there is an increased chance of the development of DVT among the geriatric aging population. Furthermore, healthcare providers are increasingly adopting IVC filters as a preventive measure for high-risk patients to reduce the occurrence of PE and its associated morbidity and mortality.
Increasing consumer awareness about the risks and consequences of diseases
There is an increase in the demand for IVC filters due to the rising awareness about the risks and consequences of DVT and PE among healthcare professionals and the general population.
Governing agencies of various countries are encouraging the adoption of IVC filters by spreading awareness, organizing campaigns, and taking educational initiatives to focus on venous thromboembolism prevention. Moreover, rapid advancements in diagnostic capabilities allow more accurate and timely detection of DVT and PE cases that enhances patient outcomes. In addition, early diagnosis allows healthcare professionals to identify individuals who could benefit from IVC filter placement. The rising utilization of IVC filters to provide a reliable and effective solution for preventing pulmonary embolism is contributing to the growth of the market.
Advancements in IVC filter technology
Various manufacturers are rapidly advancing IVC filter technology to provide improved safety and efficacy of the product. In addition, the rising introduction of retrievable IVC filters, which can be removed once the risk of pulmonary embolism has settled. These retrievable filters provide healthcare professionals with more flexibility and options for managing patients effectively, which is offering a positive market outlook. Additionally, various technological advancements in filter design and materials assist in enhancing biocompatibility and reducing the risk of adverse reactions and long-term complications. Apart from this, the rising adoption rates of IVC filters for appropriate cases due to their enhanced effectiveness.
Retrievable IVC filter represents the largest market segment
Retrievable IVC filters are medical devices that are designed to be implanted temporarily in patients at high risk of pulmonary embolism. They can be removed once the risk of clot migration has subsided or when the condition of the patient is improved. In addition, the retrievable IVC filter placement procedure is minimally invasive and typically performed by an interventional radiologist. The rising adoption of retrievable IVC filters, as they offer flexibility to healthcare providers in treatment options, is propelling the growth of the market.
Non-ferromagnetic material accounts for the majority of the market share
Non-ferromagnetic materials are those that do not contain iron and do not exhibit magnetic properties. They are used to construct filter devices and offer enhanced biocompatibility. They can withstand the physiological environment within the human body without causing adverse reactions. In addition, they are widely used in medical settings where the presence of magnetic materials could interfere with imaging techniques, such as magnetic resonance imaging (MRI). Non-ferromagnetic materials are utilized in the construction of IVC filters that allow patients to undergo MRI scans without any concerns about potential complications or distortions in the images.
Treatment venous thromboembolism (VTE) holds the biggest market share
In the treatment venous thromboembolism (VTE), the IVC filters are placed in the inferior vena cava that carries deoxygenated blood from the lower body to the heart, to trap blood clots and prevent their migration to the lungs. They assist in reducing the risk of pulmonary embolism and its potential consequences in the body. They also provide an additional layer of protection against blood clot migration in high-risk patients. In line with this, VTE treatment provides enhanced patient outcomes and improved overall safety in managing VTE cases.
Hospitals dominate the market share
Hospitals are the primary end-users of IVC filters, as they provide enhanced treatment options to patients with various medical conditions, such as those at high risk of venous thromboembolism (VTE). In hospitals, IVC filters are widely utilized in patients undergoing surgical procedures or those admitted for trauma or critical care, and individuals with known risk factors for developing deep vein thrombosis (DVT) or pulmonary embolism (PE). In addition, hospitals are equipped with advanced medical technologies and experienced healthcare professionals that benefit in managing VTE cases effectively. Interventional radiologists or vascular surgeons often perform the minimally invasive procedure of inserting IVC filters in hospital settings.
North America exhibits a clear dominance, accounting for the largest inferior vena cava (IVC) filter market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America held the biggest market share due to the presence of well-established healthcare infrastructure and facilities. In addition, the rising prevalence of obesity among individuals is contributing to the growth of the market in the region. Apart from this, the increasing utilization of IVC filters as a preventive measure among patients is supporting the growth of the market. In line with this, the rising adoption of IVC filers due to favorable regulatory framework and reimbursement policies is bolstering the growth of the market in the North America region.
Key players in the industry are investing in research and development (R&D) activities to improve the design, materials, and safety features of IVC filters. In line with this, they are developing retrievable filters, enhancing the biocompatibility of products, and exploring innovative filter designs to reduce complications and enhance patient outcomes. Apart from this, many companies are launching new IVC filter products or introducing upgraded versions of their existing products to address specific clinical needs. They are also conducting clinical trials and research studies to gather more data on the safety and efficacy of their IVC filter products. In addition, major manufacturers are working to address safety concerns related to IVC filters, such as filter migration, fracture, and perforation.
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report